MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
Mingjuan HeYixiang LiLi WangBei GuoWen MeiBiao ZhuJiajia ZhangYan DingBiying MengLiming ZhangLin XiangJing DongMin LiuLingwei XiangGuangda XiangPublished in: Diabetologia (2020)
The study demonstrates that MYDGF protects podocytes from injury and prevents the progression of DKD, providing a novel strategy for the treatment of DKD. Graphical abstract.